News archive for Translational Cancer Research
2020 evolved into an annus horribilis for everyone, manifested by physical distancing and social isolation, disrupted work routines and for many, tragic loss of livelihood and loved ones.
Best PhD prize 2019 – Andrea Gras Navarro - “Towards Natural Killer cellular Immunotherapy for glioblastoma. KIR-HLA ligand interaction and proteasome inhibitors to potentiate efficacy"
Professor Frits Thorsen and his research group at the ChiNor Research Laboratory has newly received a significant funding of 550 000 RMB over four years (equivalent to 200 000 NOK per year), from the China´s National Natural Science Foundation, for their ongoing research on exosome-derived miRNAs in brain metastases.
Rolf Bjerkvig of the group for translational cancer research has given a lecture at the Norwegian science festival "Forskningsdagene" in 2020. You can watch a video at the Norwegian Cancer Union.
Studying brain tumorigenesis and brain metastasis development through high-throughput and high-resolution brain mapping (02.04.2020)
Research leaders at the Translational Cancer Research group have newly established a research collaboration with the HUST-Suzhou Institute for Brainsmatics, to study the development of brain tumors and brain metastasis.
The brain cancer immunology and therapy group will participate at the science fair in Bergen, together with the patient organization for brain tumors, hjernesvulstforeningen.
Professor Rolf Bjerkvig at the research group for translational cancer research explains how the researchers make miniature brains and investigate how the cells move in and out of tumor tissue
There are over 100 tumor types only in the central nervous system. The Translational Cancer Research Group at the Department of Biomedicine provided data and material for a new diagnostic tool that will make it easier for cancer researchers to see the difference.
Suicide gene therapy of glioblastoma induces an immunosuppressive microenvironment.
The research laboratory for brain cancer immunology and therapy at the Department of Biomedicine has received the secretary general of the Brain-Tumour Society Rolf Ledal to discuss current and future research projects.
Injection of a genetically modified polio virus into the brain can give brain cancer patients several years more than normal treatment.
A research team led by James Lorens at the Department of Biomedicine and CCBIO used new technology to determine how breast tissue changes with age may contribute to breast cancer risk. The research is published in Cell Reports, with a commentary on Eureka Alert.
Aminur Rahman, PhD, has been awarded the American Association for Cancer Research (AACR) Scholar-in-Training Award
Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy
PhD-candidate Olivier Keunen will defend his thesis “Hyperpolarized metabolic imaging - theoretical basis and promise within clinical glioma management”